New diabetes cases linked to covid-19

[Mary Wilson]

Researchers don’t understand exactly how the disease might trigger Type 1 or Type 2 diabetes, or whether the cases are temporary or permanent. But 14 percent of those with severe covid-19 developed a form of the disorder, one analysis found.

Feb. 1, 2021 at 12:15 p.m. CST
By Erin Blakemore


Mihail Zilbermint is used to treating diabetes — he heads a special team that cares forpatients with the metabolic disorder at Suburban Hospital in Bethesda, Md. But as the hospital admitted increasing numbers of patients with covid-19, his caseload ballooned.

“Before, we used to manage maybe 18 patients per day,” he said. Now his team cares for as many as 30 daily.
Many of those patients had no prior history of diabetes. Some who developed elevated blood sugar while they had covid-19, the illness caused by the novel coronavirus, returned to normal by the time they left the hospital. Others went home with a diagnosis of full-blown diabetes. “We’ve definitely seen an uptick in patients who are newly diagnosed,” Zilbermint said.

https://www.washingtonpost.com/health/2021/02/01/covid-new-onset-diabetes/

 

[blacknail]

I have heard of this happening from multiple sources - not just in severe cases. There is a theory/conspiracy theory out there that COVID escaped from a lab and was passaged through human pancreatic and kidney cell lines.

 

[kiwibird]

https://www.sciencedirect.com/science/article/abs/pii/S1871402120304033

Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19

Highlights
•In some individuals, COVID-19 induces diabetes resembling type 1 diabetes, characterized by acute onset and DKA.
•However, their requirement for insulin diminishes after around 4–6 weeks.
•Subsequently their diabetes can be controlled with oral antihyperglycemic medicines.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237369/

An important evidence of the relationship between coronavirus and diabetes dates back to the SARS-CoV pandemic of 2003: hyperglycemia was described as an independent predictor of morbidity and mortality, in both diabetic and non-diabetic patients. Hyperglycemia was found in patients with mild respiratory symptoms, even in those not treated with glucocorticoids, reinforcing hence the hypothesis of β-cells acute damage as a consequence of the virus replicative cycle in endocrine pancreas [SUP][6][/SUP].
...
. In 2018, a cohort study investigated the relationship between T1DM and both pandemic and seasonal influenza infections: although a clear association was not demonstrated, a twofold excess of incident T1DM was found among the 76,173 patients with pandemic H1N1 infection diagnosed by laboratory or specialist healthcare [SUP][8][/SUP].
....
Given that T1DM pathogenesis has already been related to coronavirus respiratory infections [SUP][7][/SUP][SUP], [/SUP][SUP][8][/SUP], it is reasonable to suppose that an increasing incidence of T1DM may be triggered by this pandemic, with a worrisome T1DM outbreak in COVID-19 patients for the next months/years.